Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Albuterol sulfate
Drug ID BADD_D00057
Description Salbutamol is a short-acting, selective beta2-adrenergic receptor agonist used in the treatment of asthma and COPD. It is 29 times more selective for beta2 receptors than beta1 receptors giving it higher specificity for pulmonary beta receptors versus beta1-adrenergic receptors located in the heart. Salbutamol is formulated as a racemic mixture of the R- and S-isomers. The R-isomer has 150 times greater affinity for the beta2-receptor than the S-isomer and the S-isomer has been associated with toxicity. This lead to the development of levalbuterol, the single R-isomer of salbutamol. However, the high cost of levalbuterol compared to salbutamol has deterred wide-spread use of this enantiomerically pure version of the drug. Salbutamol is generally used for acute episodes of bronchospasm caused by bronchial asthma, chronic bronchitis and other chronic bronchopulmonary disorders such as chronic obstructive pulmonary disorder (COPD). It is also used prophylactically for exercise-induced asthma.[Label,A174379,A174400]
Indications and Usage For symptomatic relief and prevention of bronchospasm due to bronchial asthma, chronic bronchitis, and other chronic bronchopulmonary disorders such as COPD.
Marketing Status Discontinued; Prescription
ATC Code R03AC02; R03CC02
DrugBank ID DB01001
KEGG ID D00683
MeSH ID D000420
PubChem ID 39859
TTD Drug ID D0K5CB
NDC Product Code 17856-0740; 0591-3467; 76420-088; 50383-740; 72189-016; 0487-9901; 0487-0301; 68071-5206; 0472-0825; 59310-579; 53104-7506; 68180-963; 0378-6991; 50090-4491; 68071-4543; 72189-002; 69097-142; 68788-7996; 76204-010; 68071-1890; 51662-1267; 75834-273; 48292-0012; 63187-540; 68071-4940; 68071-2300; 0487-9904; 68084-949; 53002-2584; 76204-200; 71205-441; 12828-0063; 51407-367; 63187-026; 68788-9900; 55289-045; 76204-011; 70518-2613; 53002-1551; 55700-908; 51662-1202; 68071-2505; 53002-1584; 68071-4754; 51662-1499; 68084-952; 59310-117; 71872-7054; 50090-0517; 0378-8270; 66993-019; 72572-014; 55545-0410; 51927-1573; 72189-022; 70752-102; 71205-641; 51662-1513; 0378-6992; 68788-7702; 0254-1007; 68071-2367; 0378-0255; 50090-1329; 59651-184; 70518-1237; 45802-088; 59651-183; 55154-4350; 53002-1554; 55154-4359; 0591-3468; 53489-176; 60687-395; 50090-4143; 0054-0742; 50090-0516; 70518-2854; 0173-0682; 53002-1750; 53002-1552; 66758-959; 51407-368; 49452-0226; 68071-4048; 58032-0002; 68071-1670; 63629-2638; 50090-4977; 68788-7353; 76420-087; 76282-679; 11517-012; 0487-9501; 75834-274; 50090-3400; 0085-1132; 47335-703; 61281-3700; 68071-2656; 59310-580; 50090-4326; 50383-741; 68788-7573; 71205-211; 70518-2413; 69826-0003; 50090-1159; 59310-540; 63629-8468; 50090-5231; 51927-0151; 0093-3174; 43898-0123; 70518-1230; 53489-177; 50090-4137; 50090-5179; 69826-0002; 50090-4138; 63187-204; 0781-7296; 0378-0572; 43898-0133; 65862-858; 68071-4777; 70518-1081
Synonyms Albuterol | Salbutamol | 2-t-Butylamino-1-(4-hydroxy-3-hydroxy-3-hydroxymethyl)phenylethanol | Ventolin | Sultanol | Albuterol Sulfate | Proventil
Chemical Information
Molecular Formula C26H44N2O10S
CAS Registry Number 51022-70-9
SMILES CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.OS(=O)(=O)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Bone marrow failureBeta-2 adrenergic receptorP07550T52522Not Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Angina pectoris02.02.02.002; 24.04.04.002--
Angioedema23.04.01.001; 10.01.05.009--Not Available
Arrhythmia02.03.02.001--Not Available
Asthenia08.01.01.001--Not Available
Bronchitis22.07.01.001; 11.01.09.001--
Bronchospasm10.01.03.012; 22.03.01.004--
Chest discomfort22.02.08.001; 08.01.08.019; 02.02.02.009--Not Available
Cough22.02.03.001--
Dizziness24.06.02.007; 17.02.05.003; 02.01.02.004--
Dry throat22.02.05.004; 07.06.01.005--Not Available
Dysgeusia17.02.07.003; 07.14.03.001--
Dyspepsia07.01.02.001--
Dyspnoea22.02.01.004; 02.01.03.002--
Dysuria20.02.02.002--
Flushing24.03.01.002; 23.06.05.003; 08.01.03.025--
Headache17.14.01.001--
Hypertension24.08.02.001--
Insomnia19.02.01.002; 17.15.03.002--
Irritability19.04.02.013; 08.01.03.011--
Malaise08.01.01.003--
Muscle spasms15.05.03.004--
Nasal congestion22.04.04.001--
Nausea07.01.07.001--
Nervousness19.06.02.003--Not Available
Oropharyngeal swelling23.04.01.013; 22.04.05.005; 10.01.05.014; 07.05.04.002--Not Available
Palpitations02.01.02.003--
Pharyngitis07.05.07.004; 22.07.03.004; 11.01.13.003--
Rash23.03.13.001--Not Available
Restlessness19.11.02.002; 17.02.05.021--
Somnolence19.02.05.003; 17.02.04.006--
The 1th Page    1 2    Next   Last    Total 2 Pages